Filing Details

Accession Number:
0001179110-10-013684
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-09-10 17:30:36
Reporting Period:
2010-09-09
Filing Date:
2010-09-10
Accepted Time:
2010-09-10 17:30:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896264 Usana Health Sciences Inc USNA Medicinal Chemicals & Botanical Products (2833) 870500306
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1203302 A Gilbert Fuller 3838 West Parkway Blvd
Salt Lake City UT 84120
Cfo And Executive V.p. Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-09-09 1,127 $37.60 4,127 No 4 M Direct
Common Stock Disposition 2010-09-09 1,127 $41.50 3,000 No 4 S Direct
Common Stock Acquisiton 2010-09-09 3,720 $26.06 6,720 No 4 M Direct
Common Stock Disposition 2010-09-09 3,720 $41.50 3,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock-Settled Stock Appreciation Rights Disposition 2010-09-09 12,000 $0.00 12,000 $37.60
Common Stock Stock-Settled Stock Appreciation Rights Disposition 2010-09-09 10,000 $0.00 10,000 $26.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2011-04-26 2011-04-26 No 4 M Direct
0 2009-07-21 2011-07-21 No 4 M Direct
Footnotes
  1. The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights desclosed in Table II.